期刊文献+

EphrinB2/EphB4信号转导与肿瘤血管生成

Relationship between EphrinB2/EphB4 signaling and tumorangiogenesis
原文传递
导出
摘要 Eph/Ephrin家族是受体酪氨酸激酶家族中的最大亚族,Ephrin/Eph信号传导通路可以影响细胞形态、运动能力、细胞黏附功能、新生血管生长和肿瘤细胞增殖能力。肿瘤血管生成是肿瘤具有转移和转化能力以及复发的重要因素,在多种癌症中,Eph与Ephrin都有不同程度的表达水平改变。EphrinB2/EphB4双向信号传导通路参与了VEGF/VEGFR信号转导通路的信号转导,可显著影响肿瘤生长过程中新生血管的生长。对EphrinB2/EphB4信号传导通路的研究开辟了一条抗肿瘤血管生成的新途径。 The Eph/Ephrin subfamily is the largest family in receptor tyrosine kinase family. Ephrin/Eph signaling can significantly affect cell morphology, cell mobility, cell adhesion, angiogenesis and tumor cell proliferation. Tumorangiogenesis is essential for turmor's ability to transform and metastasis and recurrence. The expression level of Eph receptor and Ephrin ligand can both be changed in different cancers. The EphrinB2/EphB4 bidirectional signaling pathway participates in the VEGF/VEGFR signaling by mediating key receptor among VEGFR family, which can significantly affect tumor growth and angiogenesis. Tumor angiogenesis is the key regulator for tumor metastasis and recurrence. Thus, the research on EphrinB2/EphB4 signaling pathway has opened up a new way in antitumorangiogenesis.
出处 《生命的化学》 CAS CSCD 北大核心 2011年第6期849-851,共3页 Chemistry of Life
基金 浙江省科技厅面上社会发展项目(2009C33021) 国家自然科学基金项目(30701064)资助
关键词 肿瘤血管生成 Eph/Ephrin EphrinB2/EphB4 新生血管 tumorangiogenesis Eph/Ephrin EphrinB2/EphB4 angiogenesis
  • 相关文献

参考文献1

二级参考文献8

  • 1Kieran MW, Folkman J, Heymach J. Angiogenesis inhibitors and hypoxia. Nature Medicine 2003; 9:1104.
  • 2Pennacchietti S, Michieli P, GaUuzzo M, Mazzone M, Giordano S, Comoglio PM. Hypoxia promotes invasive growth by transcriptional activation of the met protoonco-gene. Cancer Cell 2003; 3:347-61.
  • 3Kerbel RS. Tumor angiogenesis. N Engl J Med 2008; 358:2039-49.
  • 4Rubenstein JL, KimJ, Ozawa T, Zhang M, Westpha M, Deen DF, et al. AntiVEGF antibody treatment of glinblastoma prolongs survival but results in increased vascular cooption. Neoplasia 2000; 2:306-14.
  • 5Ebos JM, Lee CR, Cruz-Munoz W, Bjarnason GA, Christensen JG, Kerbel RS. Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell 2009; 15:232-9.
  • 6Paez-Ribes M, Allen E, Hudock J, Takeda T, Okuyama H, Vinals F, et al. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 2009; 15:220-31.
  • 7Shaheen RM, Davis DW, Liu W, Zebrowski BK, Wilson MR, Bucana CD, et al. Antiangiogenic therapy targeting the tyrosine kinase receptor for vascular endothelial growth factor receptor inhibits the growth of colon cancer liver metastasis and induces tumor and endothelial cell apoptosis. Cancer Res 1999; 59:5412-6.
  • 8Drevs J, Hofmann I, Hugenshmidt H, Wittig C, Madjar H, Muller M, et al. Effects of PTK787/ZK 222584, a specific inhibitor of vascular endothelial growth factor receptor tyrosine kinases, on primary tumor, metastasis, vessel density and blood flow in a murine renal cell carcinoma model. Cancer Res 2000; 60:4819-24.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部